Marand Asa, Karlsson Daniel, Dalene Marianne, Skarping Gunnar
Work Environment Chemistry, Stockholm University, P. O. Box 460, S-281 24 Hassleholm, Sweden.
Analyst. 2004 Jun;129(6):522-8. doi: 10.1039/b403439b. Epub 2004 Apr 26.
Determination of amines in biological samples as markers of exposure to the amines or the corresponding isocyanates is an important tool for industrial exposure assessment. In this study, a liquid chromatography and tandem mass spectrometry (LC-MS/MS) method for determination of amines in biological samples as perfluorofatty amides derivatives is presented. The method enables determination of diamines such as methylene diamine (MDA), toluene diamine (TDA), naphthalene diamine (NDA), hexamethylene diamine (HDA), isophorone diamine (IPDA), methylenedi(cyclohexylamine)(HMDA) and 4,4'-methylene-(2-chloroaniline)(MOCA) in human urine and plasma. The work-up procedure included hydrolysis of the biological samples with 3 M H(2)SO(4) at 100 degrees C for 16 h and extraction of the amines into toluene, where derivatisation of the amines with perfluorofatty acid anhydride was performed. Following removal of excess reagent and the acid formed and an exchange of solvent, the derivatives were analysed using gradient elution with an acetonitrile/water mobile phase composition and electrospray ionisation (ESI) with multiple reaction monitoring (MRM) of M - H-->M - H - 120 or 119. Several perfluorofatty acid anhydrides were evaluated as derivatisation reagents, but the LC chromatographic properties of the pentafluoropropionic acid anhydride (PFPA) derivatives were favourable. Quantification of amine-PFPA derivatives was performed using deuterium labelled amine-PFPA derivatives as internals standards with good precision and linearity in the investigated range of 0-20 ng ml(-1) urine. The instrumental detection limits for the amine-PFPA derivatives were 0.2-3 fmol for MRM of M - H-->119 and 0.3-8 fmol for M - H-->M - H - 120. In 10 urine and 6 plasma samples from workers exposed to isocyanates, determination of TDA and MDA as PFPA derivatives was performed using LC-MS/MS and a reference GC-MS method. No significant difference between the two methods was observed.
将生物样品中的胺类作为接触胺类或相应异氰酸酯的标志物进行测定,是工业接触评估的一项重要工具。在本研究中,提出了一种液相色谱-串联质谱(LC-MS/MS)方法,用于测定生物样品中作为全氟脂肪酸酰胺衍生物的胺类。该方法能够测定人尿液和血浆中的二胺,如亚甲基二胺(MDA)、甲苯二胺(TDA)、萘二胺(NDA)、六亚甲基二胺(HDA)、异佛尔酮二胺(IPDA)、亚甲基双(环己胺)(HMDA)和4,4'-亚甲基-(2-氯苯胺)(MOCA)。后处理程序包括用3M H₂SO₄在100℃下水解生物样品16小时,然后将胺类萃取到甲苯中,在甲苯中用全氟脂肪酸酐对胺类进行衍生化。去除过量试剂和生成的酸并进行溶剂交换后,使用乙腈/水流动相组成的梯度洗脱和电喷雾电离(ESI)以及[M - H]⁻→[M - H - 120]⁻或[119]⁻的多反应监测(MRM)对衍生物进行分析。评估了几种全氟脂肪酸酐作为衍生化试剂,但五氟丙酸酐(PFPA)衍生物的LC色谱性质良好。使用氘代标记的胺-PFPA衍生物作为内标对胺-PFPA衍生物进行定量,在所研究的0-20 ng ml⁻¹尿液范围内具有良好的精密度和线性。胺-PFPA衍生物的仪器检测限对于[M - H]⁻→[119]⁻的MRM为0.2-3 fmol,对于[M - H]⁻→[M - H - 120]⁻为0.3-8 fmol。在10份来自接触异氰酸酯工人的尿液和6份血浆样品中,使用LC-MS/MS和参考GC-MS方法对作为PFPA衍生物的TDA和MDA进行了测定。两种方法之间未观察到显著差异。